poisar

Stocks · News reference

Thailand FDA Approves YONDELIS® for Advanced Soft Tissue Sarcoma

Fiscal.ai

The Thailand Food and Drug Administration has approved YONDELIS® (trabectedin) for the treatment of adult patients with advanced soft tissue sarcoma, following an exclusive licensing agreement between PharmaMar and Specialised Therapeutics.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
fiscal.ai
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading